Luigino Calzetta (Luigi Calzetta, L Calzetta, Gennaro Liccardi)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 115

Top Venues

Expert review of respiratory medicine

Expert opinion on pharmacotherapy

Journal of clinical medicine

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Luigino Calzetta, Nicola Di Daniele, Alfredo Chetta, Marco Vitale, Shima Gholamalishahi, Mario Cazzola, Rogliani Paola
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement. Journal of clinical medicine 13 (4) (2024)
Rossella Laitano, Luigino Calzetta, Matteo Matino, Elena Pistocchini, Rogliani Paola
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement. Expert opinion on pharmacotherapy (2024)
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, Mario Cazzola
An overview of the efficacy and safety of β 2 -Adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert opinion on drug safety (2024)
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, Mario Cazzola
An overview of the efficacy and safety of β 2 -adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert opinion on drug safety (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine 17 (12) (2024)
Rossella Laitano, Luigino Calzetta, Matteo Matino, Elena Pistocchini, Rogliani Paola
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement. Expert opinion on pharmacotherapy (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs 33 (1) (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs 33 (1) (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine (2024)
Rogliani Paola, Gian Marco Manzetti, Federica Roberta Bettin, Maria D'Auria, Luigino Calzetta
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert opinion on investigational drugs (2024)
Rossella Laitano, Luigino Calzetta, Matteo Matino, Elena Pistocchini, Rogliani Paola
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement. Expert opinion on pharmacotherapy 25 (8) (2024)
Luigino Calzetta, Nicola Di Daniele, Alfredo Chetta, Marco Vitale, Shima Gholamalishahi, Mario Cazzola, Rogliani Paola
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement. Journal of clinical medicine 13 (4) (2024)
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, Mario Cazzola
An overview of the efficacy and safety of β 2 -adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert opinion on drug safety 23 (7) (2024)
Luigino Calzetta, Rogliani Paola
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease. Expert review of respiratory medicine 17 (12) (2024)
Mario Cazzola, Rogliani Paola, Josuel Ora, Luigino Calzetta, Davide Lauro, Maria Gabriella Matera
Hyperglycaemia and Chronic Obstructive Pulmonary Disease. Diagnostics (Basel, Switzerland) 13 (21) (2023)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, Rogliani Paola
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 11 (2) (2023)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, Rogliani Paola
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 11 (2) (2023)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy 24 (3) (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy 24 (3) (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Rossella Laitano, Luigino Calzetta, Francesco Cavalli, Mario Cazzola, Rogliani Paola
Delivering monoclonal antibodies via inhalation: A systematic review of clinical trials in asthma and COPD. Expert opinion on drug delivery (2023)
Rogliani Paola, Rossella Laitano, Josuel Ora, Richard Beasley, Luigino Calzetta
Strength of association between comorbidities and asthma: a meta-analysis. European respiratory review : an official journal of the European Respiratory Society 32 (167) (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine 16 (11-12) (2023)
Gian Marco Manzetti, Josuel Ora, Arianna Sepiacci, Mario Cazzola, Rogliani Paola, Luigino Calzetta
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement. International journal of chronic obstructive pulmonary disease 18 (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine 16 (11-12) (2023)
Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, Rogliani Paola, Mario Cazzola
Experimental drugs in clinical trials for COPD: Artificial Intelligence via Machine Learning approach to predict the successful advance from early-stage development to approval. Expert opinion on investigational drugs (2023)
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Rogliani Paola, Maria Gabriella Matera
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert review of respiratory medicine (2023)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy 23 (2) (2022)
Annalisa Frizzelli, Francesco Di Spigno, Luca Moderato, Geza Halasz, Marina Aiello, Panagiota Tzani, Gaia Manari, Luigino Calzetta, Roberta Pisi, Giovanna Pelà, Massimo Piepoli, Alfredo Chetta
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-COVID Patients with Normal Spirometry and Unexplained Dyspnoea. Journal of clinical medicine 11 (24) (2022)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Francesca Camardelli, Mario Cazzola, Rogliani Paola, Alfredo Chetta
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis. Cells 11 (11) (2022)
Annalisa Frizzelli, Francesco Di Spigno, Luca Moderato, Geza Halasz, Marina Aiello, Panagiota Tzani, Gaia Manari, Luigino Calzetta, Roberta Pisi, Giovanna Pelà, Massimo Piepoli, Alfredo Chetta
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-COVID Patients with Normal Spirometry and Unexplained Dyspnoea. Journal of clinical medicine 11 (24) (2022)
Rogliani Paola, Clive Peter Page, Luigino Calzetta
Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options. Expert opinion on pharmacotherapy 23 (7) (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy 23 (2) (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Annalisa Frizzelli, Francesco Di Spigno, Luca Moderato, Geza Halasz, Marina Aiello, Panagiota Tzani, Gaia Manari, Luigino Calzetta, Roberta Pisi, Giovanna Pelà, Massimo Piepoli, Alfredo Chetta
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-COVID Patients with Normal Spirometry and Unexplained Dyspnoea. Journal of clinical medicine 11 (24) (2022)
Luigino Calzetta, Paola Rogliani
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab". Advances in therapy 39 (8) (2022)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Elena Pistocchini, Beatrice Ludovica Ritondo, Rogliani Paola, Alfredo Chetta
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma. Biomedicines 10 (9) (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu, Rogliani Paola
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert opinion on pharmacotherapy (2022)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute, Rogliani Paola
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. European respiratory review : an official journal of the European Respiratory Society 31 (164) (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy (2022)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Beatrice Ludovica Ritondo, Elena Pistocchini, Rogliani Paola, Alfredo Chetta
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis. Pharmaceutics 14 (8) (2022)
Mario Cazzola, Josuel Ora, Luigino Calzetta, Rogliani Paola, Maria Gabriella Matera
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? Expert opinion on pharmacotherapy 23 (8) (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Mario Cazzola, Clive Peter Page, Rogliani Paola, Luigino Calzetta, Maria Gabriella Matera
Dual bronchodilation for the treatment of COPD: From bench to bedside. British journal of clinical pharmacology 88 (8) (2022)
Mario Cazzola, Rogliani Paola, Silvio Naviglio, Luigino Calzetta, Maria Gabriella Matera
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert opinion on pharmacotherapy 23 (10) (2022)
Annalisa Frizzelli, Francesco Di Spigno, Luca Moderato, Geza Halasz, Marina Aiello, Panagiota Tzani, Gaia Manari, Luigino Calzetta, Roberta Pisi, Giovanna Pelà, Massimo Piepoli, Alfredo Chetta
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-COVID Patients with Normal Spirometry and Unexplained Dyspnoea. Journal of clinical medicine 11 (24) (2022)
Josuel Ora, Bartolomeo Zerillo, Patrizia De Marco, Gian Marco Manzetti, Ilaria De Guido, Luigino Calzetta, Rogliani Paola
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance. Journal of clinical medicine 11 (17) (2022)
Mario Cazzola, Rogliani Paola, Luigino Calzetta, Josuel Ora, Maria Gabriella Matera
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert review of clinical pharmacology 15 (3) (2022)
Rogliani Paola, Josuel Ora, Francesco Cavalli, Mario Cazzola, Luigino Calzetta
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score. Journal of clinical medicine 11 (15) (2022)
Annalisa Frizzelli, Francesco Di Spigno, Luca Moderato, Geza Halasz, Marina Aiello, Panagiota Tzani, Gaia Manari, Luigino Calzetta, Roberta Pisi, Giovanna Pelà, Massimo Piepoli, Alfredo Chetta
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-COVID Patients with Normal Spirometry and Unexplained Dyspnoea. Journal of clinical medicine 11 (24) (2022)
Rogliani Paola, Francesco Cavalli, Alfredo Chetta, Mario Cazzola, Luigino Calzetta
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile. Journal of asthma and allergy 15 (2022)
Mario Cazzola, Rogliani Paola, Rossella Laitano, Luigino Calzetta, Maria Gabriella Matera
Beyond Dual Bronchodilation - Triple Therapy, When and Why. International journal of chronic obstructive pulmonary disease 17 (2022)
Luigino Calzetta, Alfredo Chetta, Marina Aiello, Elena Pistocchini, Rogliani Paola
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review. International journal of molecular sciences 23 (23) (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy (2022)
Maria Gabriella Matera, Luigino Calzetta, Mario Cazzola, Josuel Ora, Rogliani Paola
Biologic therapies for chronic obstructive pulmonary disease. Expert opinion on biological therapy 23 (2) (2022)
Rogliani Paola, Luigino Calzetta
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies. Journal of experimental pharmacology 14 (2022)
Maria Gabriella Matera, Luigino Calzetta, Josuel Ora, Rogliani Paola, Mario Cazzola
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert opinion on drug delivery 18 (7) (2021)
Rogliani Paola, Luigino Calzetta
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs. Expert opinion on pharmacotherapy 22 (7) (2021)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Giuseppina Bertorelli, Rogliani Paola, Alfredo Chetta
Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence. International journal of molecular sciences 22 (13) (2021)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Alfredo Chetta, Rogliani Paola
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies. Expert review of respiratory medicine (2021)
Josuel Ora, Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Rogliani Paola
Current long-acting muscarinic antagonists for the treatment of asthma. Expert opinion on pharmacotherapy 22 (17) (2021)
Luigino Calzetta, Beatrice Ludovica Ritondo, Angelo Coppola, Maria Gabriella Matera, Nicola Di Daniele, Paola Rogliani
Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials. Vaccines 9 (4) (2021)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Giuseppina Bertorelli, Beatrice Ludovica Ritondo, Rogliani Paola, Alfredo Chetta
The Impact of Monoclonal Antibodies on Airway Smooth Muscle Contractility in Asthma: A Systematic Review. Biomedicines 9 (9) (2021)
Roberta Pisi, Marina Aiello, Annalisa Frizzelli, Luigino Calzetta, Laura Marchi, Giuseppina Bertorelli, Giovanna Pisi, Alfredo Chetta
Detection of Small Airway Dysfunction in Asymptomatic Smokers with Preserved Spirometry: The Value of the Impulse Oscillometry System. International journal of chronic obstructive pulmonary disease 16 (2021)
Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera
Long-acting muscarinic antagonists and small airways in asthma: Which link? Allergy 76 (7) (2021)
Maria Gabriella Matera, Luigino Calzetta, Rosa Annibale, Francesco Russo, Mario Cazzola
Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert review of clinical pharmacology 14 (8) (2021)
Luigino Calzetta, Angelo Coppola, Beatrice Ludovica Ritondo, Matteo Matino, Alfredo Chetta, Rogliani Paola
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review. International journal of chronic obstructive pulmonary disease 16 (2021)
Mario Cazzola, Maria Gabriella Matera, Rogliani Paola, Luigino Calzetta, Josuel Ora
Step-up and step-down approaches in the treatment of asthma. Expert review of respiratory medicine 15 (9) (2021)
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Rogliani Paola, Alfredo Chetta
Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom. Journal of clinical medicine 10 (8) (2021)
Rogliani Paola, Beatrice Ludovica Ritondo, Luigino Calzetta
Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies. The European respiratory journal 58 (3) (2021)
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, Rogliani Paola, Mario Cazzola
Sex differences in COPD management. Expert review of clinical pharmacology 14 (3) (2021)
Luigino Calzetta, Antonio Pietroiusti, Clive Peter Page, Ovidio Bussolati, Alfredo Chetta, Francesco Facciolo, Rogliani Paola
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine. Expert review of respiratory medicine 15 (11) (2021)
Luigino Calzetta, Beatrice Ludovica Ritondo, Patrizia de Marco, Mario Cazzola, Rogliani Paola
Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies. Expert review of respiratory medicine 15 (1) (2020)
Josuel Ora, Angelo Coppola, Mario Cazzola, Luigino Calzetta, Rogliani Paola
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease. Journal of experimental pharmacology 12 (2020)
Beatrice Ludovica Ritondo, Ermanno Puxeddu, Luigino Calzetta, Mario Cazzola, Rogliani Paola
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review. Expert opinion on pharmacotherapy 22 (5) (2020)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Gabriella Pezzuto, Mario Cazzola, Paola Rogliani
Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD). Expert opinion on investigational drugs 29 (7) (2020)
Rogliani Paola, Beatrice Ludovica Ritondo, Rossella Laitano, Alfredo Chetta, Luigino Calzetta
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD. Expert review of respiratory medicine 15 (1) (2020)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Francesco Facciolo, Rogliani Paola
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab. British journal of pharmacology 177 (20) (2020)
Rogliani Paola, Beatrice Ludovica Ritondo, Ermanno Puxeddu, Gloria Pane, Mario Cazzola, Luigino Calzetta
Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review. Journal of experimental pharmacology 12 (2020)
Josuel Ora, Luigino Calzetta, Maria Gabriella Matera, Mario Cazzola, Rogliani Paola
Advances with glucocorticoids in the treatment of asthma: state of the art. Expert opinion on pharmacotherapy 21 (18) (2020)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Mario Cazzola, Paola Rogliani
Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review. Expert review of respiratory medicine 14 (6) (2020)
Rogliani Paola, Beatrice Ludovica Ritondo, Mariachiara Gabriele, Mario Cazzola, Luigino Calzetta
Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings. Expert review of clinical pharmacology 13 (9) (2020)
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani, Mario Cazzola
The role of triple therapy in the management of COPD. Expert review of clinical pharmacology 13 (8) (2020)
Rogliani Paola, Maria Gabriella Matera, Francesco Facciolo, Clive Page, Mario Cazzola, Luigino Calzetta
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo. British journal of pharmacology 177 (5) (2020)
Rogliani Paola, Davide Lauro, Nicola Di Daniele, Alfredo Chetta, Luigino Calzetta
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? Expert review of respiratory medicine 15 (4) (2020)
Mario Cazzola, Rogliani Paola, Luigino Calzetta, Maria Gabriella Matera
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy. Pharmacogenomics and personalized medicine 13 (2020)
Paola Rogliani, Beatrice Ludovica Ritondo, Bartolomeo Zerillo, Mario Cazzola, Maria Gabriella Matera, Luigino Calzetta
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination. COPD 17 (2) (2020)
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani
Monoclonal antibodies in severe asthma: is it worth it? Expert opinion on drug metabolism & toxicology 15 (6) (2019)
Rogliani Paola, Luigino Calzetta, Maria Gabriella Matera, Nicola di Daniele, Andrea Girolami, Mario Cazzola, Josuel Ora
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease. Expert opinion on pharmacotherapy 20 (6) (2019)
Luigino Calzetta, R Crupi, P Roncada, E Pistocchini, D di Cave, I Rossi, G Cito, G A Jacobson, D Britti
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference. Equine veterinary journal 52 (2) (2019)
Paola Rogliani, Luigino Calzetta, Josuel Ora, Mario Cazzola, Maria Gabriella Matera
Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis. Multidisciplinary respiratory medicine 14 (2019)
Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera, Rossella Laitano, Beatrice Ludovica Ritondo, Nicola A Hanania, Mario Cazzola
Severe Asthma and Biological Therapy: When, Which, and for Whom. Pulmonary therapy 6 (1) (2019)
Luigino Calzetta, Maria Gabriella Matera, Mario Cazzola, Paola Rogliani
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients. Advances in therapy 36 (12) (2019)

Luigino Calzetta.css-eqlu8i{font-size:small;padding-left:4px;} (Luigi Calzetta, L Calzetta, Gennaro Liccardi)

Publication Activity (10 Years)

Top Topics

Top Venues

Luigino Calzetta (Luigi Calzetta, L Calzetta, Gennaro Liccardi)